LifeStance Health Group, Inc. (LFST)
Nasdaq · Healthcare · Medical Care Facilities
$12.22+3.30%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $4.6B
- P/E (trailing)
- 94.0
- Forward P/E
- 28.4
- 52-week range
- $4.77 – $13.56
- 52-week change
- +113.92%
- EPS (trailing)
- $0.13
- Analyst rating
- 1.5 Strong buy
- Next earnings
- Nov 5, 2026
Fiscal year to Dec 2025
- Revenue
- $1.4B (+13.85%)
- Net income
- $9.7M
- Operating margin
- 1.7%
- Free cash flow
- $110M
From the company’s annual report on SEC EDGAR.
About LifeStance Health Group, Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
Headquarters: Scottsdale, United States · 8,542 employees · lifestance.com